diagnosi
respiratori
virus
tradit
reli
cultur
antigen
detectionw
aim
demonstr
capac
rtpcresim
platform
identifi
clinic
relev
respiratori
virus
nasopharyng
aspir
npa
sampl
compar
diagnost
perform
characterist
rel
convent
cultureand
antigenbas
method
rtpcresim
respiratori
viru
surveil
kit
design
detect
respiratori
syncyti
viru
influenza
b
parainfluenza
type
adenovirida
type
af
coronavirida
human
bocaviru
human
metapneumoviru
evalu
use
mockup
frozen
archiv
npa
posit
clinic
virolog
method
rtpcresim
detect
known
posit
sampl
identifi
addit
cultur
neg
sampl
virus
nondetect
convent
method
also
identifi
viral
load
semiquantifi
rang
time
result
rtpcresim
show
promis
rapid
detect
respiratori
virus
merit
evalu
use
clinic
set
acut
respiratori
tract
infect
rti
consid
forgotten
pandem
remain
lead
caus
caus
mortal
children
worldwid
bryce
et
al
spite
public
health
prevent
measur
advanc
therapeut
incid
rate
rti
unit
state
vari
littl
past
year
monto
et
al
etiolog
diagnosi
remain
challeng
lack
broad
base
rapid
accur
diagnost
tool
lead
overprescrib
antibiot
delay
definit
diagnosi
potenti
increas
complic
ineffect
epidem
control
molecular
diagnost
assay
greatest
potenti
impact
clinic
practic
infecti
agent
virus
convent
microbiolog
method
ie
cultur
provid
time
result
ratcliff
et
al
nucleic
acid
amplif
test
naat
develop
multipl
individu
virus
liolio
et
al
util
clinic
set
extend
avail
singl
platform
system
simultan
detect
multipl
pathogen
liao
et
al
pabbaraju
et
al
raymond
et
al
wu
et
al
electrospray
ioniz
mass
spectrometri
follow
broadrang
revers
transcriptionpcr
rtpcresim
one
singl
system
platform
potenti
rapidli
detect
semiquantifi
differ
pathogen
simulaten
date
studi
rtpcremim
restrict
evalu
individu
respiratori
bacteria
virus
ie
streptococcu
coronaviru
sar
adenoviru
russel
et
al
influenza
virus
sampath
et
al
detail
character
eg
resist
gene
recognit
genotyp
organ
capac
rtpcremim
broad
rang
detect
rapid
turnaround
may
provid
use
tool
clinician
health
care
set
aid
earli
diagnosi
rti
aim
demonstr
capac
rtpcresim
platform
identifi
subtyp
multipl
respiratori
virus
nasopharyng
aspir
npa
examin
perform
characterist
rtpcresim
platform
pilot
hospitalbas
retrospect
proof
concept
studi
seven
clinic
relev
viral
pathogen
coronaviru
respiratori
syncyti
viru
rsv
influenza
b
parainfluenza
type
adenoviru
coronaviru
sar
obtain
zeptometrix
given
concentr
buffalo
ny
pool
neg
npa
test
rtpcresim
use
mockup
experi
determin
limit
detect
lod
serial
dilut
genom
copieswel
genom
copiesml
spike
neg
nasopharyng
aspir
npa
concentr
repeat
five
time
indepent
ensur
precis
lod
determin
least
concentr
five
five
repeat
detect
rtpcresim
clinic
sampl
deriv
patient
present
suspect
respiratori
tract
infect
tertiari
inner
citi
teach
hospit
accord
standard
collect
procedur
may
novemb
excess
clinic
sampl
store
nucleic
acid
extract
microbiolog
databas
queri
standard
clinic
virolog
result
includ
rapid
immunochromatograph
test
influenza
rsv
binex
inver
bedford
uk
direct
fluoresc
antibodi
stain
test
ultra
dfa
respiratori
viru
id
kit
diagnost
hybrid
athen
oh
rapid
shell
vial
cultur
identif
rmix
diagnost
hybrid
athen
oh
roller
tube
cultur
hemadsorpt
test
figur
routin
pcr
test
perform
clinic
virolog
laboratori
two
neg
npa
clinic
virolog
obtain
match
posit
sampl
month
collect
studi
approv
john
hopkin
univers
institut
review
board
sampl
process
total
nucleic
acid
extract
use
thermo
kingfish
waltham
robot
accord
ambion
abi
foster
citi
ca
magmax
viral
kit
extract
protocol
sampl
process
dedic
investig
kc
mask
clinic
virolog
laboratori
result
time
process
onestep
rtpcr
perform
reaction
mix
consist
u
amplitaq
gold
appli
biosystem
foster
citi
ca
mm
tri
ph
mm
kcl
mm
mbetain
mmmix
datp
dgtp
dctp
dttp
biolin
usa
inc
randolph
mm
dithiothreitol
ng
sonic
polya
dna
sigma
corp
st
loui
mo
ng
random
hexam
rt
invitrogen
corp
carlsbad
ca
u
superasin
ambion
corp
austin
tx
ng
gene
protein
roch
diagnost
corp
indianapoli
u
superscript
iii
invitrogen
corp
carlsbad
ca
mm
sorbitol
sigma
corp
nm
specif
pcr
primer
rtpcr
cycl
condit
min
min
min
min
follow
cycl
second
second
second
anneal
temperatur
increas
cycl
rtpcr
continu
addit
cycl
second
second
second
rtpcr
cycl
end
final
extens
min
follow
hold
rtpcr
use
rna
dna
viru
amplif
assay
perform
use
ibi
respiratori
viru
surveil
ii
kit
ibi
bioscienc
inc
carlsbad
ca
design
detect
subtyp
virus
seven
group
convent
virus
rsv
influenza
b
parainfluenza
type
adenovirida
type
af
virus
convent
identifi
clinic
virolog
laboratori
coronavirida
human
bocaviru
human
metapneumoviru
researchuseonli
kit
primer
pair
distribut
plate
well
contain
one
pair
primer
virus
two
primer
set
set
primer
influenza
virus
plate
abl
test
six
patient
sampl
specimen
test
well
ibi
platform
perform
autom
postpcr
desalt
esim
signal
acquisit
spectral
analysi
data
report
analyz
rtpcr
product
describ
previous
briefli
step
follow
ul
aliquot
pcr
reaction
desalt
purifi
use
weak
anion
exchang
protocol
describ
elsewher
ward
et
al
accur
mass
ppm
highresolut
fullwidth
halfmaximum
mass
spectra
acquir
sampl
use
highthroughput
esim
protocol
describ
previous
sampath
et
al
sampl
approxim
ul
analyt
solut
consum
spectral
acquisit
raw
mass
spectra
postcalibr
intern
mass
standard
deconvolv
monoisotop
molecular
mass
unambigu
base
composit
deriv
exact
mass
measur
complementari
singlestrand
oligonucleotid
semiquantit
result
pathogen
obtain
compar
peak
height
intern
pcr
calibr
intern
mass
standard
present
everi
pcr
well
molecul
also
treat
intern
posit
control
well
neg
control
implement
batch
process
steril
viral
transport
media
well
clinic
virolog
laboratori
perform
pcr
test
routin
respiratori
virus
accordingli
sampl
clinic
virolog
laboratori
rtpcr
esim
agre
enough
remain
volum
sent
viracor
lee
summit
mo
identif
anoth
pcrbase
platform
luminex
respiratori
assay
austin
tx
abl
detect
virus
rtpcresim
could
detect
except
human
bocaviru
pabbaraju
et
al
sampl
throughput
rtpcresim
includ
use
one
kingfish
extract
robot
one
janu
autom
dispens
robot
four
eppendorf
thermocycl
one
cleanup
inject
autom
system
evalu
primari
analysi
evalu
perform
rtpcresim
standard
clinic
virolog
laboratori
result
use
refer
test
figur
describ
number
subject
one
npa
sampl
evalu
number
evalu
result
oper
defin
purpos
primari
secondari
perform
evalu
number
individu
evalu
result
could
compar
one
anoth
sinc
npa
sampl
could
yield
test
result
cultur
rtpcrmsesi
neg
singl
posit
multipl
viral
detect
figur
secondari
analysi
combin
clinic
virolog
laboratori
result
secondari
ie
luminex
pcrbase
result
refer
test
sampl
contain
virus
hospit
clinic
virolog
laboratori
protocol
avail
ie
bocaviru
coronaviru
detect
exclud
primari
analysi
includ
secondari
analysi
viral
agent
could
detect
luminex
rtpcrbase
method
ie
virus
except
bocaviru
confid
interv
sensit
specif
base
exact
binomi
probabl
twosampl
wilcoxon
mannwhitney
test
use
compar
viral
load
clinic
virolog
posit
group
neg
group
mock
npa
sampl
seven
virus
group
detect
success
rtpcresim
level
copieswel
figur
rtpcresim
sensit
detect
adenoviru
least
sensit
detect
rsv
lod
genom
copieswel
respect
figur
exclus
overal
agreement
confid
interv
ci
sensit
specif
exclud
nonconvent
virus
jhu
identif
protocol
coronaviru
metapneumoviru
ci
ci
respect
tabl
among
sampl
result
avail
first
accuraci
analysi
sampl
found
disagre
rtpcresim
clinic
virolog
laboratori
individu
pathogen
identifi
clinic
virolog
rtpcresim
detect
rsv
adenoviru
parainfluenza
influenza
virus
tabl
rtpcresim
also
success
subtyp
eight
influenza
five
influenza
b
two
parainfluenza
type
parainfluenza
type
identifi
clinic
virolog
well
seven
adenoviru
type
b
c
clinic
virolog
protocol
subtyp
misssubtyp
one
parainfluenza
type
one
parainfluenza
type
identifi
virolog
laboratori
parainfluenza
type
parainfluenza
type
respect
median
storag
time
month
rang
viral
load
semiquantifi
rtpcresim
rang
copi
ml
viral
load
rtpcresim
posit
sampl
clinic
virolog
neg
group
significantli
lower
clinic
virolog
posit
group
median
vs
copiesml
respect
figur
among
origin
sampl
result
disagr
rtpcresim
convent
virolog
assay
jhu
protocol
suffici
volum
sent
anoth
pcrbase
method
confirm
rtpcresim
result
includ
posit
convent
virus
influenza
rsv
parainfluenza
two
coronaviru
metapneumoviru
detect
detect
convent
clinic
virolog
protocol
confirm
well
overal
agreement
sensit
specif
secondari
analysi
avail
sampl
ci
ci
respect
tabl
time
first
result
sampl
prepar
detect
rtpcresim
hour
hour
rna
extract
hour
rtpcr
hour
process
esim
estim
throughput
rtpcresim
sampl
technician
work
hour
repres
pcr
reaction
studi
hospitalbas
retrospect
pilot
proofofconcept
studi
design
demostr
capac
determin
perform
novel
rtpcresim
platform
mockup
sampl
previous
frozen
clinic
sampl
compar
clinic
virolog
assay
studi
show
novel
assay
rapid
abl
detect
subtyp
multipl
respiratori
pathogen
hospit
accuraci
compar
convent
clinic
virolog
assay
studi
also
indic
pathogen
detect
tradit
clinic
virolog
method
could
success
detect
rtpcresim
platform
rtpcresim
platform
sever
advantag
includ
rapid
turnaround
time
detail
pathogen
character
ie
rel
semiquantif
type
subtyp
speci
versu
convent
cultur
method
current
common
diagnost
method
clinic
virolog
laboratori
culturebas
may
take
day
yield
result
laborintens
expens
anzueto
et
al
although
rapid
antigen
test
offer
faster
detect
time
individu
lower
sensit
specif
limit
clinic
util
sole
methodolog
ginocchio
rtpcresim
platform
capabl
detect
multipl
pathogen
effici
high
sensit
well
abil
determin
quantiti
pathogen
would
potenti
biomark
infect
cours
sever
howev
prospect
valid
studi
need
determin
clinic
perform
assay
determin
perform
novel
assay
similar
problem
appear
discord
analysi
result
new
assay
refer
standard
test
research
confirm
result
novel
assay
discord
convent
cultur
rapid
antigen
test
anoth
multiplex
rtpcr
assay
liolio
et
al
pabbaraju
et
al
remain
controversi
regard
examin
potenti
accur
novel
assay
versu
current
alloy
standard
dore
et
al
propos
clinic
evid
infect
includ
valid
novel
nucleic
acid
test
dore
et
al
howev
studi
design
permit
detail
clinic
data
collect
recogn
sever
limit
design
first
oper
rtpcresim
perform
almost
year
initi
test
done
clinic
virolog
util
excess
npa
obtain
clinic
virolog
result
specimen
process
year
collect
patient
although
effect
length
storag
npa
shown
minim
within
month
ward
et
al
impact
longer
period
storag
remain
unknown
ward
et
al
demonstr
multipl
freez
thaw
cycl
significantli
alter
concentr
measur
prior
freez
influenza
sampl
ward
et
al
frisbi
et
al
indic
influenza
rna
could
degrad
freezer
may
result
loss
sensit
frisbi
et
al
second
limit
could
send
everi
specimen
secondari
analys
due
insuffici
volum
sampl
inher
limit
retrospect
design
use
howev
sinc
almost
half
discord
result
verifi
anoth
pcrbase
method
might
littl
impact
estim
futur
studi
merit
perform
parallel
comparison
everi
sampl
anoth
refer
test
eg
anoth
pcr
base
method
order
better
character
perform
platform
thirdli
could
test
perform
rtpcresim
everi
subtyp
clinic
revel
respiratori
virus
design
studi
viral
subtyp
demonstr
pilot
studi
ie
parainfluenza
type
adenoviru
type
df
studi
requir
determin
perform
novel
platform
lastli
perform
five
repeat
lod
experi
util
detect
criteria
determin
lod
detect
rule
gener
appli
lod
studi
althought
fewer
repeat
studi
may
limit
precis
lod
detect
still
consid
conserv
estim
pilot
studi
could
provid
evid
futher
studi
conclus
demonstr
innov
rtpcresim
technolog
could
rapidli
accur
detect
subtyp
virus
identifi
convent
virolog
method
detect
convent
virus
miss
clinic
virolog
unconvent
virus
requir
addit
confirmatatori
test
determin
perform
characterist
rtpcresim
method
promis
diagnost
platform
rapid
identif
convent
unconvent
virus
merit
prospect
evalu
diagnost
algorithm
use
clinic
virolog
laboratori
detect
respiratori
virus
mainli
divid
respiratori
season
nonrespiratori
season
respiratori
season
defin
octob
follow
januari
octob
novemb
rsv
decemb
januari
influenza
immunochromatograph
assay
use
respiratori
season
sole
screen
test
rsv
influenza
stop
test
algorithm
result
posit
respiratori
panel
cocktail
dfa
test
serv
adenoviru
influenza
b
parainfluenza
type
rsv
stop
test
algorithm
result
posit
nonrespiratori
season
screen
neg
immunochromatograph
assay
respiratori
season
well
bocaviru
detect
clinic
virolog
laboratori
anoth
pcrbase
platform
exclud
exclud
coronaviru
human
metapneumovirusdetect
clinic
virolog
laboratori
protocol
detect
includ
primari
perform
analysi
tabl
twentyf
sampl
clinic
virolog
laboratori
rtpcresim
agre
clinic
virolog
laboratori
protocol
detect
suffici
volum
left
sent
anoth
pcrbase
assay
secondari
analysi
seven
clinic
relev
viral
pathogen
coronaviru
respiratori
syncyti
viru
rsv
influenza
b
parainfluenza
type
adenoviru
coronaviru
sar
spike
pool
neg
npa
test
rtpcresim
determin
limit
detect
lod
five
repeat
serial
dilut
copieswel
copiesml
rtpcresim
sensit
detect
adenoviru
lod
copieswel
least
sensit
detect
rsv
lod
copi
well
one
copieswel
approxim
copiesml
overal
agreement
sensit
specif
exclud
nonconvent
virus
jhu
identif
protocol
respect
exclud
virus
coronaviru
bocaviru
metapneumoviru
detect
rtpcresim
clinic
virolog
identif
protocol
diagn
microbiol
infect
di
author
manuscript
avail
pmc
februari
